|A robust dual reporter system to visualize and quantify gene expression mediated by transcription activator-like effectors.|
|Jump to Full Text|
|PMID: 22871120 Owner: NLM Status: PubMed-not-MEDLINE|
|BACKGROUND: Transcription activator-like effectors (TALEs) are a class of naturally occurring transcription effectors that recognize specific DNA sequences and modulate gene expression. The modularity of TALEs DNA binding domain enables sequence-specific perturbation and offers broad applications in genetic and epigenetic studies. Although the efficient construction of TALEs has been established, robust functional tools to assess their functions remain lacking.
RESULTS: We established a dual reporter system that was specifically designed for real-time monitoring and quantifying gene expression mediated by TALEs. We validated both sensitivity and specificity of this dual-reporter system in mammalian cells, and demonstrated that this dual reporter system is robust and potentially amenable to high throughput (HTP) applications.
CONCLUSION: We have designed, constructed and validated a novel dual reporter system for assessing TALE mediated gene regulations. This system offers a robust and easy-to- use tool for real-time monitoring and quantifying gene expression in mammalian cells.
|Claudia Uhde-Stone; Joseph Huang; Biao Lu|
|Type: Journal Article Date: 2012-08-08|
|Title: Biological procedures online Volume: 14 ISSN: 1480-9222 ISO Abbreviation: Biol Proced Online Publication Date: 2012|
|Created Date: 2012-11-29 Completed Date: 2012-11-30 Revised Date: 2013-04-02|
Medline Journal Info:
|Nlm Unique ID: 100963717 Medline TA: Biol Proced Online Country: England|
|Languages: eng Pagination: 8 Citation Subset: -|
|System Biosciences (SBI), 265 North Whisman Road, Mountain View CA 94043, USA. email@example.com.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Biol Proced Online
Journal ID (iso-abbrev): Biol Proced Online
Publisher: BioMed Central
Copyright ©2012 Uhde-Stone et al.; licensee BioMed Central Ltd.
Received Day: 20 Month: 7 Year: 2012
Accepted Day: 22 Month: 7 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 8 Month: 8 Year: 2012
Volume: 14First Page: 8 Last Page: 8
PubMed Id: 22871120
Publisher Id: 1480-9222-14-8
|A robust dual reporter system to visualize and quantify gene expression mediated by transcription activator-like effectors|
|Claudia Uhde-Stone1||Email: Claudia.firstname.lastname@example.org|
|Joseph Huang2||Email: JHuang@kensonventures.com|
|Biao Lu2||Email: email@example.com|
1Departments of Biological Sciences, California State University, East Bay, Hayward CA 94542, USA
2System Biosciences (SBI), 265 North Whisman Road, Mountain View CA 94043, USA
Zinc-finger nucleases (ZFNs) and meganucleases have been well-established as tools to edit specific sites in complex genomes [1,2]. However, the DNA-binding domain of zinc-finger nucleases are challenging to design and require experimental optimization, and the target sequences of meganucleases are limited. Transciption activator-like effector (TALE) technology has recently emerged as an alternative robust and efficient genome editing tool [3,4]. Natural TALEs are transcription factors used by plant-pathogenic bacteria in the genus Xanthomonas. The native function of TALEs is to modulate host gene expression by binding to specific sequences in host gene promoters and activate transcription [5,6]. The DNA binding domain of TALEs consist of a central domain of 33–35 amino acid repeats arranged in tandem, followed by a single truncated repeat of 20 amino acids. The tandem repeats are nearly identical, except for two variable amino acids in position 12 and 13, referred to as “repeat-variable di-residue” (RVD), with the four most common RVDs each specifying binding of one of the four DNA bases [7,8]. The modular nature of the TALE DNA-binding domain and the straightforward sequence relationships enables efficient customization of TAL effector repeat domains. The simplicity of TALE design and construction to target nearly any DNA sequence within the genome has been an important advantage of the technology [9,10].
TALEs with customized DNA-binding domains can be fused to the catalytic domain of the FokI nuclease to create targeted DNA double-strand breaks in vivo for genome editing [11-15]. TAL effector nucleases (TALENs) function in pairs, as FokI cleaves DNA upon dimerization. Double-strand breaks will be repaired in most cells by non-homologous end joining, which frequently results in small deletions or insertions, thus leading to potential gene disruption. Alternatively, homologous recombination in presence of a donor sequence can be harnessed for gene insertion or replacement . Recently, engineered TALENs have been shown as a robust gene editing tool in a number of species [4,16-20]. Similarly, sequence-specific TALEs for modulating eukaryotic gene activation or repression have also been reported [21,22]. With the availability of efficient assembly of TALEs for use in mammalian cells, attention starts to shift to develop functional monitoring tools. Although a single reporter system using either fluorescent protein or luciferase has been reported, neither system is commercially available or amenable to HTP applications . Here we demonstrated the design, construction and validation of a novel dual-reporter system for the real-time monitoring and quantification of gene expression mediated by TALEs. With the simplicity and robustness of this dual reporter system, this novel tool offers a solution for functional assessment of gene regulation mediated by TALEs with high sensitivity and specificity.
The dual reporter for TALEs was designed to make use of the unique property of two reporters: green fluorescent protein (GFP) and firefly luciferase. While GFP by itself offers a visual, real-time monitoring of gene activation, the quantification is time-consuming and requires the use of expensive analysis machine such as flow cytometry. To overcome this limitation, we designed a dual reporter, which combines GFP with a quantifiable luciferase (Figure 1a). Because luciferase reporter can provide a cost-effective way of quantification, together this dual reporter system offers a powerful tool superior to any single reporter system.
To monitor TALE-induced gene expression, a minimal promoter is required to turn on the transcription of down-stream reporters. We chose the minimal CMV promoter (mCMV), which has been demonstrated to function in various mammalian cells. To minimize the non-specific influence of transcription, cares were taken to mutate the potential transcription binding sites within the backbone. In addition, a transcription stopper sequence was placed before the TALE binding sites, directly upstream of a multiple cloning site (MCS) (Figure 1a). To evaluate the background activities, a promoterless reporter was constructed as negative control (Figure 1b). Similarly, a full-length CMV promoter reporter was constructed as positive control to validate experimental parameters such as transfection conditions and efficiencies (Figure 1c).
We next determined the function of these reporters in mammalian cells. As expected, transfection of human embryonic kidney cells (HEK293) with promoterless reporter showed no GFP-positive cells and was used to establish background-level luciferase activity (Figure 1d). Under the same experimental conditions, a few GFP-positive cells were detected for the dual reporter with mCMV promoter (Figure 1e). In contrast, more than 85% cells showed GFP positive for the positive control reporter (Figure 1f). A low to moderate level (695-fold increase vs. promoterless control) of luciferase activity was detected for the minimal promoter, while a very robust level (>150000-fold increase vs. promoterless controls) was observed for the positive control reporter (Figure 1g). These results demonstrated the desired functions of our dual reporter system. Two key features are worthy to note: first, the dual reporter has very low background noise and potentially very high signal levels in mammalian cells (HEK293 cells, Figure 1). Secondly, the low to moderate basal activity of the dual reporter offers a potential capability to monitor both an increase or decrease in gene expression (unpublished data).
To facilitate monitoring the transcription activity of TALE-TF (transcription factor), multiple cloning sites were readily placed at the immediate upstream of the mCMV. In this way, TALE-TF binding sites will be in optimal position for transcriptional activation (within 200 bp upstream of transcription start sites). Of note ~3-5 binding sites are normally engineered into reporter construct to increase the sensitivity of reporters (Figure 1h).
We next investigated the specificity of dual reporters in the context of monitoring TALE-TF. The programmable nature of TALEs allows for a virtually arbitrary selection of any target DNA-binding site. We chose the Sox2-TALE-TF, as this TALE has been previously demonstrated to be able to activate both the endogenous Sox2 gene and a reporter . As shown in Figure 2, we constructed two Sox2-TALE-TF expression vectors: one with a CMV promoter to achieve high expression and the other with an EF1a promoter to achieve moderate expression (Figure 2a). The Sox2-TALE-TF binding sequences were deduced from the Sox2 effector binding domain, and used for construction of its dual reporter (Figure 2a). Specifically, a double-stranded DNA fragment containing three binding sites were synthesized, PCR-amplified and subsequently cloned into the MCS. To avoid potential interference of DNA binding to the tandem binding sites, each target sites were inserted with an arbitrary spacer (5-bp). A similar reporter with unrelated repeat sequences was also built as negative control (Figure 2a).
To evaluate the specificity of the above reporters, a co-transfection experiment was conducted in HEK293 cells. As shown in Figure 2b (the upper 2nd panel), when the Sox2 binding site reporter was co-transfected with the Sox2-TALE-TF, >85% HEK293 cells were GFP positive. In contrast, barely any GFP positive cells showed up in the mock transfection controls using empty vector DNA lacking the Sox2-TALE-TF (Figure 2b, the upper 1st panel). Correspondingly, a 221-fold increase in luciferase activity was observed in co-transfected cells, while the mock control displayed only low activity. Because the only difference of these two constructs are the TALE-binding sites, these data strongly support that the dual reporter system is both a sensitive and a specific method to validate TALE activity.
To further confirm that this dual reporter configuration is useful in validating TALEs function, a new set of dual reporters were built with a different plasmid backbone, namely the minicircle plasmid DNA. To demonstrate the specificity of the dual reporter in these new vector backbones, the same co-transfection experiments were conducted. As shown in Figure 2c, Sox2-TALE-TF specifically activated reporter genes to a similar extend, with a drastic increase in the numbers of GFP-positive cells, and a 245-fold increase in luciferase activity. These results further validated that the dual reporter is useful for specifically monitoring gene activation mediated by TALEs, and indicate that the core configuration of the dual reporter can be applied to a broad range of plasmid backbones.
The above findings indicate that the dual reporters are specific and robust (> 200 fold increase), as demonstrated by two sets of vectors. To further examine the sensitivity of this dual reporter, we performed dose–response experiments. As shown in Figure 3a, as low as 1 ng effector DNA induced GFP positive cells (white arrows), and the number of GFP positive cells increased in parallel with the increasing dosages of effector DNA to a maximum of 2.5 ug tested. Consistent with GFP results, there was also a dose-dependent increase in luciferase activity. Specifically, the lowest dose of 1 ng effector DNA input resulted in a significant 15-fold increase compared to the empty-vector DNA control, while the highest dose of 2.5 ug resulted in a marked 9847-fold increase in luciferase activities. These data strongly support the notion that these dual reporters may serve as a robust functional validation system for customized TALE-TFs with both high sensitivity and specificity.
One important advantage for the use of dual reporters is that GFP allows real-time monitoring in living cells, while luciferase enables easy quantification. To test the ability of GFP as a visual tool to monitor TALE-mediated gene regulation, we conducted time-course studies using our dual reporters. As shown in Figure 4a, as early as 3 hours after transfection, a few weak GFP-positive cells were observed in HEKs co-expression of Sox2-TALE-TF with dual reporters. The number of GFP-positive cells and the intensity increased with time, reached a peak at 24 hours, and then attenuated at 30 hours. Under the same experimental condition, both the number of GFP positive cells and the intensity are much lower in the empty-vector DNA (no TALE-TF) controls (Figure 4a, lower panel), with an apparent time-delay. In agreement with GPF results, there is a corresponding increase in luciferase activity in a time-dependent manner (Figure 4b) These results confirm the specific effects of TALE-TF, as well as the feasibility of real-time monitoring of TALE-TF action by our dual reporter system. Together, these observations provide a strong correlation between the visual GFP assessment and luciferase quantification.
We have designed and built a dual reporter system for the functional evaluation of TALE-TF. In addition, we have validated specificity and sensitivity of this robust reporter system. Since this dual reporter system allows real-time monitoring and cost-effective quantification, it will add a great value to the community using TALE-TF models to study gene regulation in mammalian cells.
The dual reporter system is configured from the 5’ to 3’ as follows: a transcription stopper sequence, MCS, mCMV, GFP-T2A-Luciferase, followed by a Poly A signal (core sequence). The components of the core sequence were PCR amplified and fused together using gene fusion technology (SBI, Mountain View, CA). The above dual reporter sequences were subsequently cloned into either a regular plasmid with an ampicillin selection marker or a minicircle plasmid with a kanamycin selection marker (SBI, Mountain View). In addition, reporters without mCMV or with a full-length CMV promoter sequences were similarly constructed to serve as negative or positive controls. For TALE transcription activators, we placed the Sox2 gene activator into a lentiviral vector under the control of CMV. This Sox2-TALE-TF is designed to target a 14-mer sequence site located at the proximal promoter of the human Sox2 gene. Three binding repeats of the Sox2 14-mer or three repeats of unrelated 14-mers as negative control were subcloned into the MCS of the above dual reporters.
HEK cells were maintained in high glucose Dulbecco’s Minmal Essential Medium (DMEM) supplemented with 10% FBS, 2 mM GlutaMax (Life Technologies), penicillin/streptomycin. Cells were incubated at 37°C and 5% CO2. At ~80% confluence, cells were washed with PBS and passaged with 0.25% trypsin-EDTA for dissociation.
For transfections, HEK cells were seeded on 6-well plates at a density of 1 x 105/well, and a total of 1 ug dual reporter and 2 ug effector DNA (Sox2-TALE-TF or empty vector DNA mock control) with polymer-based transfection reagent (SBI, Mountain view, CA) were added to the media following manufacturer’s instruction. If not stated otherwise, cells were harvested 18 hours after transfection for measuring luciferase activity, using a Luciferase assay kit according to manufacturer’s instructions (Promega, Madison, WI).
For real-time monitoring, cultured cells were monitored at regular time intervals under a fluorescent microscope. GFP live cell images were taken at indicated time-points using same exposure condition within the group of comparison. For luciferase reporter assay, all data are presented as mean ± S.D. (n = 3), unless stated otherwise.
TALE: Transcription activator-like effector; GFP: Green fluorescent protein; HTP: High through put; mCMV: Minimal cytomegalovirus promoter; SBS: Sox2-binding site; UBS: Unrelated binding site.
All authors in this manuscript declare that we have no significant competing financial, professional interests that might have influenced the performance or presentation of the work described in this manuscript.
BL and CS conceived the study aims and design, contributed to the systematic review and data extraction, performed the analysis and interpreted the results. BL performed the experiments and drafted the manuscript. CS and HJ contributed to the revision of the manuscript. All authors have read and approved the final version of this paper.
|Urnov FD,Rebar EJ,Holmes MC,Zhang HS,Gregory PD,Genome editing with engineered zinc finger nucleasesNature reviews GeneticsYear: 2010119636646|
|Silva G,Poirot L,Galetto R,Smith J,Montoya G,Duchateau P,Paques F,Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapyCurrent gene therapyYear: 2011111112721182466|
|Morbitzer R,Romer P,Boch J,Lahaye T,Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factorsProceedings of the National Academy of Sciences of the United States of AmericaYear: 201010750216172162221106758|
|Hockemeyer D,Wang H,Kiani S,Lai CS,Gao Q,Cassady JP,Cost GJ,Zhang L,Santiago Y,Miller JC,et al. Genetic engineering of human pluripotent cells using TALE nucleasesNature biotechnologyYear: 2011298731734|
|Boch J,Bonas U,Xanthomonas AvrBs3 family-type III effectors: discovery and functionAnnual review of phytopathologyYear: 201048419436|
|Bogdanove AJ,Schornack S,Lahaye T,TAL effectors: finding plant genes for disease and defenseCurr Opin Plant BiolYear: 201013439440120570209|
|Boch J,Scholze H,Schornack S,Landgraf A,Hahn S,Kay S,Lahaye T,Nickstadt A,Bonas U,Breaking the code of DNA binding specificity of TAL-type III effectorsScienceYear: 200932659591509151219933107|
|Moscou MJ,Bogdanove AJ,A simple cipher governs DNA recognition by TAL effectorsScienceYear: 20093265959150119933106|
|Cermak T,Doyle EL,Christian M,Wang L,Zhang Y,Schmidt C,Baller JA,Somia NV,Bogdanove AJ,Voytas DF,Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targetingNucleic acids researchYear: 20113912e8221493687|
|Garg A,Lohmueller JJ,Silver PA,Armel TZ,Engineering synthetic TAL effectors with orthogonal target sitesYear: 2012 , Nucleic acids research|
|Clark KJ,Voytas DF,Ekker SC,A TALE of two nucleases: gene targeting for the masses?ZebrafishYear: 20118314714921929364|
|Christian M,Cermak T,Doyle EL,Schmidt C,Zhang F,Hummel A,Bogdanove AJ,Voytas DF,Targeting DNA double-strand breaks with TAL effector nucleasesGeneticsYear: 2010186275776120660643|
|Li T,Huang S,Jiang WZ,Wright D,Spalding MH,Weeks DP,Yang B,TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domainNucleic acids researchYear: 201139135937220699274|
|Miller JC,Tan S,Qiao G,Barlow KA,Wang J,Xia DF,Meng X,Paschon DE,Leung E,Hinkley SJ,et al. A TALE nuclease architecture for efficient genome editingNature biotechnologyYear: 2011292143148|
|Mahfouz MM,Li L,Shamimuzzaman M,Wibowo A,Fang X,Zhu JK,De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaksProceedings of the National Academy of Sciences of the United States of AmericaYear: 201110862623262821262818|
|Li T,Huang S,Zhao X,Wright DA,Carpenter S,Spalding MH,Weeks DP,Yang B,Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotesNucleic acids researchYear: 201139146315632521459844|
|Li T,Liu B,Spalding MH,Weeks DP,Yang B,High-efficiency TALEN-based gene editing produces disease-resistant riceNature biotechnologyYear: 2012305390392|
|Liu J,Li C,Yu Z,Huang P,Wu H,Wei C,Zhu N,Shen Y,Chen Y,Zhang B,et al. Efficient and Specific Modifications of the Drosophila Genome by Means of an Easy TALEN StrategyJournal of genetics and genomics = Yi chuan xue baoYear: 201239520921522624882|
|Mahfouz MM,Li L,TALE nucleases and next generation GM cropsGM CropsYear: 2011229910321865862|
|Moore FE,Reyon D,Sander JD,Martinez SA,Blackburn JS,Khayter C,Ramirez CL,Joung JK,Langenau DM,Improved Somatic Mutagenesis in Zebrafish Using Transcription Activator-Like Effector Nucleases (TALENs)PloS oneYear: 201275e3787722655075|
|Li L,Piatek MJ,Atef A,Piatek A,Wibowo A,Fang X,Sabir JS,Zhu JK,Mahfouz MM,Rapid and highly efficient construction of TALE-based transcriptional regulators and nucleases for genome modificationPlant Mol BiolYear: 2012784–540741622271303|
|Mahfouz MM,Li L,Piatek M,Fang X,Mansour H,Bangarusamy DK,Zhu JK,Targeted transcriptional repression using a chimeric TALE-SRDX repressor proteinPlant Mol BiolYear: 201278331132122167390|
|Mussolino C,Morbitzer R,Lutge F,Dannemann N,Lahaye T,Cathomen T,A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicityNucleic acids researchYear: 201139219283929321813459|
|Zhang F,Cong L,Lodato S,Kosuri S,Church GM,Arlotta P,Efficient construction of sequence-specific TAL effectors for modulating mammalian transcriptionNature biotechnologyYear: 2011292149153|
Keywords: Dual reporter, Gene editing, Transcription activator-like effector, Green fluorescent protein, Firefly luciferase.
Previous Document: Application of mathematical modeling for the development and optimization formulation with bioactive...
Next Document: Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in Africa...